Noting the historic WHO recommendation of the RTS,S malaria vaccine on 6 October 2021, the Board of the RBM Partnership to End Malaria celebrates and...Read more.
Historic moment for the global malaria community as first malaria vaccine recommended for widespread use among children in Africa
Geneva, 6 October 2021 – The RBM Partnership to End Malaria welcomes today’s historic recommendation by the World Health Organization (WHO) to scale...Read more.
At its 19th Board Meeting, the RBM Partnership to End Malaria Board voted in four new Members: Dr John Chimumbwa, Executive Director, Southern...Read more.
Geneva, 24 September 2021 - In line with the RBM Board Rotation Policy approved in November 2017, the RBM Partnership is seeking to appoint several...Read more.
RBM Partnership welcomes new commitments to malaria innovation, including mRNA platform and local manufacturing for malaria vaccine
Geneva, 26 July 2021 -- The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to...Read more.
30 June 2021 – Today, the World Health Organization (WHO) officially certified China malaria-free. The RBM Partnership welcomes China’s...Read more.
Geneva/Seattle, June 29, 2021 — The fight against malaria can no longer be gender blind, contends a new report, “Achieving a Double Dividend: The...Read more.
Photo credits: World Health Organization
Geneva, 5th May 2021 – The RBM Partnership to End Malaria welcomes ongoing efforts to innovate and scale up life-saving new tools to tackle malaria,...Read more.